Combination of ablation and immunotherapy for hepatocellular carcinoma: where we are and where to go
K Wang, C Wang, H Jiang, Y Zhang, W Lin… - Frontiers in …, 2021 - frontiersin.org
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths
worldwide and is increasing in incidence. Local ablative therapy plays a leading role in HCC …
worldwide and is increasing in incidence. Local ablative therapy plays a leading role in HCC …
AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
This guidance document provides an updated approach to the prevention, diagnosis, and
treatment of hepatocellular carcinoma (HCC). The prior American Association for the Study …
treatment of hepatocellular carcinoma (HCC). The prior American Association for the Study …
Surgical approach to microwave and radiofrequency liver ablation for hepatocellular carcinoma and colorectal liver metastases less than 5 cm: a systematic review …
M Abdalla, AT Collings, R Dirks, E Onkendi… - Surgical …, 2023 - Springer
Background Primary hepatocellular carcinoma (HCC) and colorectal liver metastases
(CRLM) represent the two most common malignant neoplasms of the liver. The objective of …
(CRLM) represent the two most common malignant neoplasms of the liver. The objective of …
Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score–matched study
H Zheng, K Liu, Y Yang, B Liu, X Zhao, Y Chen… - European …, 2022 - Springer
Objectives Thermal ablation is now accepted as one of the curative treatments for patients
with early-stage hepatocellular carcinoma (HCC), but the efficacy of this treatment for …
with early-stage hepatocellular carcinoma (HCC), but the efficacy of this treatment for …
Comparing Long-Term survival benefits of hepatocellular carcinoma between thermal ablation monotherapy and combined therapy with transarterial …
K Zhang, L Mu, Y Ren, T Jiang - European Journal of Radiology, 2023 - Elsevier
Purpose To compare the long-term survival benefits of hepatocellular carcinoma (HCC) in
thermal ablation (TA) monotherapy and TA combined with transarterial chemoembolization …
thermal ablation (TA) monotherapy and TA combined with transarterial chemoembolization …
[HTML][HTML] New next-generation microwave thermosphere ablation for small hepatocellular carcinoma
H Tamai, J Okamura - Clinical and molecular hepatology, 2021 - ncbi.nlm.nih.gov
Methods This retrospective study analyzed 513 patients with 630 HCCs (≤ 3 cm) who were
performed by percutaneous RFA (174 patients, 214 HCCs) or MTA (339 patients, 416 …
performed by percutaneous RFA (174 patients, 214 HCCs) or MTA (339 patients, 416 …
Comparisons of radiofrequency ablation, microwave ablation, and irreversible electroporation by using propensity score analysis for early stage hepatocellular …
T Wada, K Sugimoto, K Sakamaki, H Takahashi… - Cancers, 2023 - mdpi.com
Simple Summary This single-center retrospective study aimed to compare the therapeutic
and safety outcomes of radiofrequency ablation (RFA), microwave ablation (MWA), and …
and safety outcomes of radiofrequency ablation (RFA), microwave ablation (MWA), and …
[HTML][HTML] Complication rates and risk of recurrence after percutaneous radiofrequency ablation and microwave ablation for the treatment of liver tumors: a meta-analysis
AS Alhasan, TS Daqqaq, MS Alhasan, HA Ghunaim… - Academic …, 2024 - Elsevier
Rationale and Objectives The rate of complications and risk of local recurrence following
percutaneous radiofrequency ablation (RFA) and microwave ablation (MWA) for liver tumors …
percutaneous radiofrequency ablation (RFA) and microwave ablation (MWA) for liver tumors …
Local-regional treatment of hepatocellular carcinoma: A primer for radiologists
N Horvat, AI De Oliveira, B Clemente de Oliveira… - Radiographics, 2022 - pubs.rsna.org
The treatment planning for patients with hepatocellular carcinoma (HCC) relies
predominantly on tumor burden, clinical performance, and liver function test results. Curative …
predominantly on tumor burden, clinical performance, and liver function test results. Curative …
Long-term outcome of percutaneous radiofrequency ablation for periportal hepatocellular carcinoma: tumor recurrence or progression, survival and clinical …
S Cao, T Lyu, Z Fan, H Guan, L Song, X Tong, J Wang… - Cancer Imaging, 2022 - Springer
Background/aim Recent studies have suggested that periportal location of percutaneous
radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) is considered as one of …
radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) is considered as one of …